Cite
MLA Citation
Xiaohan Chi et al.. “BOB: Bayesian optimal design for biosimilar trials with co‐primary endpoints.” Statistics in medicine, vol. 41, 2022, pp. 5319–5334. http://access.bl.uk/ark:/81055/vdc_100168595022.0x000045
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Xiaohan Chi et al.. “BOB: Bayesian optimal design for biosimilar trials with co‐primary endpoints.” Statistics in medicine, vol. 41, 2022, pp. 5319–5334. http://access.bl.uk/ark:/81055/vdc_100168595022.0x000045